Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It raises the concentration of glucose and fatty acids in the bloodstream and is considered to be the main catabolic hormone of the body. It is also used as a medication to treat a number of health conditions.
Glucagon-like peptide-1, GLP-1), -1, ( ). -1 L- , ...
Furthermore, visual representations like the one above help us fully grasp the concept of Alpha-Cell-Restoration-And-Glucagon-Like-Peptide-One-Interactions.
Objective: Glucagon-like peptide-1 (GLP-1) is insulinotropic, but its effect on the -cell is less clear. We investigated the dose-response relationship for GLP-1-induced glucagon suppression in patients with type 2 diabetes (T2DM) and healthy controls.
Background: The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects of GLP-1 are the glucose-dependent stimulation of insulin secretion, decrease of gastric emptying, inhibition of food intake...
Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials. Diabetes Obes Metab.
Glucagon-like peptide 1 (GLP-1) ScienceDirect.
Glucagon-like peptide-1 (GLP-1) receptor agonists are approved by the Food and Drug Administration for treatment of type 2 diabetes mellitus and cardiovascular risk reduction in this cohort (see table).1 In addition, GLP-1 receptor agonists are also used for weight loss.
